Your browser is no longer supported. Please, upgrade your browser.
VTRS [NASD]
Viatris Inc.
IndexS&P 500 P/E- EPS (ttm)-1.91 Insider Own0.24% Shs Outstand1.21B Perf Week-2.52%
Market Cap17.89B Forward P/E3.93 EPS next Y3.74 Insider Trans0.00% Shs Float1.21B Perf Month7.70%
Income-1921.10M PEG- EPS next Q0.83 Inst Own75.40% Short Float1.77% Perf Quarter6.38%
Sales17.17B P/S1.04 EPS this Y-6.10% Inst Trans0.26% Short Ratio2.03 Perf Half Y5.54%
Book/sh17.48 P/B0.84 EPS next Y0.73% ROA-3.30% Target Price18.85 Perf Year-14.10%
Cash/sh0.69 P/C21.19 EPS next 5Y-0.35% ROE-8.90% 52W Range11.96 - 18.68 Perf YTD8.50%
Dividend0.44 P/FCF8.85 EPS past 5Y-21.60% ROI-0.40% 52W High-21.41% Beta1.33
Dividend %3.00% Quick Ratio0.70 Sales past 5Y4.80% Gross Margin34.40% 52W Low22.74% ATR0.37
Employees45000 Current Ratio1.10 Sales Q/Q52.60% Oper. Margin-4.90% RSI (14)58.26 Volatility3.02% 2.33%
OptionableYes Debt/Eq1.11 EPS Q/Q-28.40% Profit Margin-11.20% Rel Volume1.01 Prev Close14.36
ShortableYes LT Debt/Eq0.94 EarningsNov 08 BMO Payout- Avg Volume10.48M Price14.68
Recom2.40 SMA201.50% SMA508.18% SMA2004.35% Volume10,865,359 Change2.23%
Jun-15-21Initiated Citigroup Neutral $16
Apr-07-21Resumed RBC Capital Mkts Outperform $24
Mar-08-21Downgrade Goldman Buy → Neutral $20 → $15
Mar-02-21Downgrade JP Morgan Overweight → Neutral $21 → $18
Feb-26-21Downgrade Wolfe Research Outperform → Peer Perform $17
Jan-05-21Initiated Argus Hold
Dec-14-20Initiated Bernstein Mkt Perform $21
Jan-25-22 09:38PM  
Jan-24-22 06:15PM  
Jan-21-22 05:55AM  
Jan-20-22 01:05PM  
11:32AM  
08:08AM  
04:30AM  
Jan-19-22 05:38PM  
01:38PM  
01:38PM  
Jan-17-22 06:00PM  
05:52AM  
Jan-13-22 09:38PM  
05:38PM  
01:38PM  
Jan-12-22 06:15PM  
08:32AM  
Jan-08-22 07:00AM  
Jan-07-22 05:38PM  
Jan-06-22 12:30PM  
07:00AM  
Jan-03-22 02:14PM  
Jan-02-22 05:55AM  
Dec-29-21 08:30PM  
Dec-28-21 11:00AM  
06:05AM  
Dec-22-21 05:53AM  
Dec-21-21 07:45AM  
Dec-17-21 05:15PM  
09:36AM  
Dec-15-21 01:07PM  
Dec-14-21 11:38PM  
Dec-11-21 12:38AM  
Dec-09-21 01:12PM  
01:28AM  
12:43AM  
12:28AM  
Dec-08-21 06:38PM  
11:56AM  
04:30AM  
Dec-07-21 03:16PM  
Dec-06-21 08:37AM  
08:00AM  
06:54AM  
Dec-01-21 06:59AM  
Nov-30-21 02:29PM  
06:40AM  
Nov-25-21 05:55AM  
Nov-24-21 09:31AM  
Nov-22-21 06:55AM  
06:00AM  
Nov-21-21 06:55AM  
Nov-18-21 06:59AM  
Nov-17-21 02:27PM  
05:55AM  
Nov-16-21 06:59AM  
Nov-13-21 11:00AM  
Nov-12-21 04:11PM  
05:51AM  
Nov-11-21 11:38AM  
06:59AM  
Nov-10-21 10:53AM  
Nov-08-21 02:30PM  
02:16PM  
10:01AM  
08:35AM  
06:59AM  
Nov-07-21 06:04AM  
Nov-05-21 10:09AM  
Nov-04-21 09:39AM  
Nov-02-21 05:50PM  
07:43AM  
Nov-01-21 03:02PM  
Oct-27-21 10:14AM  
05:52AM  
Oct-25-21 10:39AM  
Oct-23-21 06:15AM  
Oct-22-21 10:19AM  
05:52AM  
Oct-21-21 08:30AM  
Oct-20-21 01:23PM  
11:37AM  
07:05AM  
07:00AM  
Oct-16-21 06:04AM  
Oct-15-21 09:29AM  
06:45AM  
Oct-14-21 05:51AM  
Oct-13-21 08:00AM  
Oct-11-21 07:30AM  
Oct-07-21 08:15AM  
Oct-06-21 05:51AM  
Oct-04-21 11:41AM  
Oct-01-21 08:45PM  
Sep-29-21 02:26PM  
05:51AM  
Sep-28-21 05:47AM  
Sep-27-21 06:00AM  
Sep-17-21 05:32PM  
05:19PM  
Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COURY ROBERT JExecutive ChairmanJun 24Option Exercise0.00250,00001,633,587Jun 25 07:00 PM
CORNWELL W DONDirectorMay 21Buy15.455007,7255,000May 21 06:00 PM
CORNWELL W DONDirectorMay 19Buy15.791,50023,6904,500May 21 06:00 PM
CORNWELL W DONDirectorMar 03Buy13.843,00041,5153,000Mar 04 06:35 PM
Lyons Dillon JoEllenDirectorMar 02Option Exercise0.009,440025,049Mar 04 06:36 PM
MARK RICHARD ADirectorMar 02Option Exercise0.009,440018,668Mar 04 06:36 PM
Malik RajivPresidentMar 02Option Exercise0.00174,0170174,017Mar 04 06:36 PM
van der Meer Mohr PaulineDirectorMar 02Option Exercise0.009,440015,705Mar 04 06:35 PM
KORMAN HARRYDirectorMar 02Option Exercise0.009,440036,141Mar 04 06:35 PM
HIGGINS MELINA EDirectorMar 02Option Exercise0.009,440048,571Mar 04 06:35 PM
PARRISH MARK WDirectorMar 02Option Exercise0.009,440067,753Mar 04 06:35 PM
Mauro AnthonySee RemarksMar 02Option Exercise0.0076,5650173,164Mar 04 06:35 PM
Campbell PaulSee RemarksMar 02Option Exercise0.001,67501,823Mar 04 06:35 PM
Campbell PaulSee RemarksMar 02Option Exercise0.0022,874046,133Mar 04 06:35 PM
DIMICK NEIL FDirectorMar 02Option Exercise0.009,440060,703Mar 04 06:35 PM
GOETTLER MICHAELChief Executive OfficerFeb 22Option Exercise0.003,49907,603Feb 24 06:01 PM